Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 9.34B | 8.68B | 9.72B | 10.40B | 8.01B | 8.83B |
Gross Profit | 9.14B | 0.00 | 9.72B | 10.40B | 8.01B | 8.83B |
EBITDA | 947.00M | 478.00M | 0.00 | 2.01B | 0.00 | 1.53B |
Net Income | 433.00M | 954.00M | 632.00M | 972.00M | 333.00M | 559.00M |
Balance Sheet | ||||||
Total Assets | 560.50B | 548.42B | 552.20B | 551.29B | 569.87B | 552.49B |
Cash, Cash Equivalents and Short-Term Investments | 34.13B | 0.00 | 33.31B | 30.16B | 36.79B | 40.12B |
Total Debt | 1.39B | 11.56B | 18.27B | 18.73B | 35.23B | 25.38B |
Total Liabilities | 531.12B | 519.07B | 520.89B | 5.23B | 537.55B | 518.90B |
Stockholders Equity | 28.50B | 28.45B | 30.43B | 29.40B | 31.48B | 32.79B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.35B | 2.18B | -19.88B | 11.13B | 11.56B |
Operating Cash Flow | 0.00 | 1.65B | 2.64B | -19.22B | 11.28B | 11.69B |
Investing Cash Flow | 0.00 | -2.09B | 972.00M | 13.79B | -13.30B | -19.21B |
Financing Cash Flow | 0.00 | -2.19B | -272.00M | -272.00M | -341.00M | -273.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $1.07T | 13.96 | 6.63% | 2.58% | 11.33% | 20.11% | |
72 Outperform | ¥573.20B | 12.01 | 8.39% | 2.98% | 7.15% | 44.42% | |
71 Outperform | ¥435.76B | 9.74 | 1.16% | 33.00% | 80.88% | ||
70 Outperform | ¥856.06B | 11.38 | 7.77% | 3.03% | 10.63% | 12.90% | |
68 Neutral | ¥72.19B | 7.10 | 2.50% | 14.57% | 45.13% | ||
67 Neutral | ¥836.32B | 13.01 | 9.24% | 3.02% | 7.93% | 10.80% | |
61 Neutral | ¥8.85B | 8.45 | 3.08% | -9.75% | 81.65% |